| 32.74 1.06 (3.35%) | 07-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 41.7 |
1-year : | 45.61 |
| Resists | First : | 35.7 |
Second : | 39.04 |
| Pivot price | 34.68  |
|||
| Supports | First : | 30.29 |
Second : | 25.2 |
| MAs | MA(5) : | 32.53 |
MA(20) : | 34.62 |
| MA(100) : | 26.86 |
MA(250) : | 35.3 |
|
| MACD | MACD : | 0.4 |
Signal : | 1.1 |
| %K %D | K(14,3) : | 13.8 |
D(3) : | 13.4 |
| RSI | RSI(14): 48.9 |
|||
| 52-week | High : | 70.43 | Low : | 13.73 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ HIMS ] has closed above bottom band by 24.3%. Bollinger Bands are 16.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 35.88 - 36.13 | 36.13 - 36.33 |
| Low: | 30.39 - 30.63 | 30.63 - 30.81 |
| Close: | 32.42 - 32.8 | 32.8 - 33.1 |
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Thu, 23 Jul 2026
Hims & Hers Health (HIMS) Gains On FDA Panel News, Is The Valuation Gap Still Wide? - Yahoo Finance
Thu, 23 Jul 2026
What the FDA’s Peptide Decision Means for Hims & Hers’ Long-Term Telehealth Strategy - Barron's
Thu, 23 Jul 2026
Hims, The Surprise Winner Of The FDA Showdown With Peptides, Bounds Higher - Investor's Business Daily
Thu, 23 Jul 2026
Quest Shines As Deals With Hims, Oura Bolster Consumer Biz - Investor's Business Daily
Thu, 23 Jul 2026
Hims & Hers Stock Pops on FDA Panel’s Peptide Recommendation - Barron's
Thu, 23 Jul 2026
Here’s Why Hims & Hers Stock Soared 13% Today – July 23, 2026 - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 223 (M) |
| Shares Float | 211 (M) |
| Held by Insiders | 5.5 (%) |
| Held by Institutions | 70 (%) |
| Shares Short | 61,170 (K) |
| Shares Short P.Month | 62,610 (K) |
| EPS | -0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.92 |
| Profit Margin | -0.6 % |
| Operating Margin | -8 % |
| Return on Assets (ttm) | 0.6 % |
| Return on Equity (ttm) | -2.7 % |
| Qtrly Rev. Growth | 3.7 % |
| Gross Profit (p.s.) | 7.75 |
| Sales Per Share | 10.62 |
| EBITDA (p.s.) | 0.37 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 280 (M) |
| Levered Free Cash Flow | 174 (M) |
| PE Ratio | -363.78 |
| PEG Ratio | 2.1 |
| Price to Book value | 16.96 |
| Price to Sales | 3.08 |
| Price to Cash Flow | 26.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|